The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-Hydroxy-4-((4-(naphthalen-2-yl)thiazol-2-yl)amino)-benzoic Acid ID: ALA4520531
PubChem CID: 7328982
Max Phase: Preclinical
Molecular Formula: C20H14N2O3S
Molecular Weight: 362.41
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)c1ccc(Nc2nc(-c3ccc4ccccc4c3)cs2)cc1O
Standard InChI: InChI=1S/C20H14N2O3S/c23-18-10-15(7-8-16(18)19(24)25)21-20-22-17(11-26-20)14-6-5-12-3-1-2-4-13(12)9-14/h1-11,23H,(H,21,22)(H,24,25)
Standard InChI Key: HUECFCSRZKSRJF-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
4.1254 -27.1102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5364 -26.4016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1249 -25.6914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3023 -25.6942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3578 -26.4018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8370 -27.0640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6184 -26.8075 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.6186 -25.9861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8373 -25.7335 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3258 -25.5723 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0410 -25.9750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0439 -26.7950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7583 -27.2018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4677 -26.7831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4582 -25.9576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7433 -25.5587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3059 -27.1091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9008 -26.4061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0908 -26.4084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6849 -27.1130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0990 -27.8125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9076 -27.8067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1651 -25.5406 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.1834 -27.1890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1913 -28.0103 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.8871 -26.7694 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17 1 2 0
1 2 1 0
2 3 2 0
3 4 1 0
4 18 2 0
2 5 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
8 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
15 23 1 0
14 24 1 0
24 25 2 0
24 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 362.41Molecular Weight (Monoisotopic): 362.0725AlogP: 5.11#Rotatable Bonds: 4Polar Surface Area: 82.45Molecular Species: ACIDHBA: 5HBD: 3#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 3.34CX Basic pKa: 1.82CX LogP: 5.59CX LogD: 2.36Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.47Np Likeness Score: -1.14
References 1. Bestgen B, Kufareva I, Seetoh W, Abell C, Hartmann RW, Abagyan R, Le Borgne M, Filhol O, Cochet C, Lomberget T, Engel M.. (2019) 2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of Action., 62 (4): [PMID:30689946 ] [10.1021/acs.jmedchem.8b01765 ] 2. Lindenblatt D, Nickelsen A, Applegate VM, Jose J, Niefind K.. (2020) Structural and Mechanistic Basis of the Inhibitory Potency of Selected 2-Aminothiazole Compounds on Protein Kinase CK2., 63 (14): [PMID:32589844 ] [10.1021/acs.jmedchem.0c00587 ] 3. Brear P,Ball D,Stott K,D'Arcy S,Hyvönen M. (2020) Proposed Allosteric Inhibitors Bind to the ATP Site of CK2α., 63 (21.0): [PMID:33119282 ] [10.1021/acs.jmedchem.0c01173 ]